In Q3 2026 Medicare started paying for obesity drugs at a $50 copay, Lilly booked $23.0 billion in a single quarter, and private capital put $1.15 billion into companies that measure the body. In the same ninety days a Phase 2a trial used six proteomic clocks to read biological age as a clinical endpoint. Your customers can now buy a reading of their biological age. Rejuvenation therapies produced no clinical data inside the quarter.